J Alexandra Rowe1, D Herbert Opi, Thomas N Williams. 1. Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, University of Edinburgh, Edinburgh, UK. Alex.Rowe@ed.ac.uk
Abstract
PURPOSE OF REVIEW: This review summarizes recent advances in our understanding of the interaction between malaria parasites and blood group antigens and discusses how the knowledge gleaned can be used to target the development of new antimalarial treatments and vaccines. RECENT FINDINGS: Studies of the interaction between Plasmodium vivax and the Duffy antigen provide the clearest example of the potential for basic research on blood groups and malaria to be translated into a vaccine that could have a major impact on global health. Progress is also being made in understanding the effects of other blood group antigens on malaria. After years of controversy, the effect of ABO blood groups on falciparum malaria has been clarified, with the non-O blood groups emerging as significant risk factors for life-threatening malaria, through the mechanism of enhanced rosette formation. The Knops blood group system may also influence malaria susceptibility, although conflicting results from different countries mean that further research is required. Unanswered questions remain about the interactions between malaria parasites and other blood group antigens, including the Gerbich, MNS and Rhesus systems. SUMMARY: The interplay between malaria parasites and blood group antigens remains a fascinating subject with potential to contribute to the development of new interventions to reduce the global burden of malaria.
PURPOSE OF REVIEW: This review summarizes recent advances in our understanding of the interaction between malaria parasites and blood group antigens and discusses how the knowledge gleaned can be used to target the development of new antimalarial treatments and vaccines. RECENT FINDINGS: Studies of the interaction between Plasmodium vivax and the Duffy antigen provide the clearest example of the potential for basic research on blood groups and malaria to be translated into a vaccine that could have a major impact on global health. Progress is also being made in understanding the effects of other blood group antigens on malaria. After years of controversy, the effect of ABO blood groups on falciparum malaria has been clarified, with the non-O blood groups emerging as significant risk factors for life-threatening malaria, through the mechanism of enhanced rosette formation. The Knops blood group system may also influence malaria susceptibility, although conflicting results from different countries mean that further research is required. Unanswered questions remain about the interactions between malaria parasites and other blood group antigens, including the Gerbich, MNS and Rhesus systems. SUMMARY: The interplay between malaria parasites and blood group antigens remains a fascinating subject with potential to contribute to the development of new interventions to reduce the global burden of malaria.
Authors: Candelaria Vergara; Yuhjung J Tsai; Audrey V Grant; Nicholas Rafaels; Li Gao; Tracey Hand; Maria Stockton; Monica Campbell; Dilia Mercado; Mezbah Faruque; Georgia Dunston; Terri H Beaty; Ricardo Riccio Oliveira; Eduardo V Ponte; Alvaro A Cruz; Edgar Carvalho; Maria Ilma Araujo; Harold Watson; Robert P Schleimer; Luis Caraballo; Renate G Nickel; Rasika A Mathias; Kathleen C Barnes Journal: Am J Respir Crit Care Med Date: 2008-09-30 Impact factor: 21.405
Authors: Weijing He; Stuart Neil; Hemant Kulkarni; Edward Wright; Brian K Agan; Vincent C Marconi; Matthew J Dolan; Robin A Weiss; Sunil K Ahuja Journal: Cell Host Microbe Date: 2008-07-17 Impact factor: 21.023
Authors: Francis B Ntumngia; Amy M McHenry; John W Barnwell; Jennifer Cole-Tobian; Christopher L King; John H Adams Journal: Am J Trop Med Hyg Date: 2009-02 Impact factor: 2.345
Authors: David Reich; Michael A Nalls; W H Linda Kao; Ermeg L Akylbekova; Arti Tandon; Nick Patterson; James Mullikin; Wen-Chi Hsueh; Ching-Yu Cheng; Josef Coresh; Eric Boerwinkle; Man Li; Alicja Waliszewska; Julie Neubauer; Rongling Li; Tennille S Leak; Lynette Ekunwe; Joe C Files; Cheryl L Hardy; Joseph M Zmuda; Herman A Taylor; Elad Ziv; Tamara B Harris; James G Wilson Journal: PLoS Genet Date: 2009-01-30 Impact factor: 5.917
Authors: Emiliana Tjitra; Nicholas M Anstey; Paulus Sugiarto; Noah Warikar; Enny Kenangalem; Muhammad Karyana; Daniel A Lampah; Ric N Price Journal: PLoS Med Date: 2008-06-17 Impact factor: 11.069
Authors: Panita Gosi; Srisin Khusmith; Thareerat Khalambaheti; David E Lanar; Kurt E Schaecher; Mark M Fukuda; Scott R Miller Journal: Malar J Date: 2008-06-26 Impact factor: 2.979
Authors: Sheila Akinyi; Eric Hanssen; Esmeralda V S Meyer; Jianlin Jiang; Cindy C Korir; Balwan Singh; Stacey Lapp; John W Barnwell; Leann Tilley; Mary R Galinski Journal: Mol Microbiol Date: 2012-04-27 Impact factor: 3.501
Authors: Samuel B Anyona; Prakasha Kempaiah; Evans Raballah; Gregory C Davenport; Tom Were; Stephen N Konah; John M Vulule; James B Hittner; Charity W Gichuki; John M Ong'echa; Douglas J Perkins Journal: Am J Hematol Date: 2012-06-23 Impact factor: 10.047
Authors: Jill R Storry; Magnus Jöud; Mikael Kronborg Christophersen; Britt Thuresson; Bo Åkerström; Birgitta Nilsson Sojka; Björn Nilsson; Martin L Olsson Journal: Nat Genet Date: 2013-04-07 Impact factor: 38.330
Authors: Patience B Tetteh-Quarcoo; Christoph Q Schmidt; Wai-Hong Tham; Richard Hauhart; Haydyn D T Mertens; Arthur Rowe; John P Atkinson; Alan F Cowman; J Alexandra Rowe; Paul N Barlow Journal: PLoS One Date: 2012-04-10 Impact factor: 3.240
Authors: Maria M M Kaisar; Taniawati Supali; Aprilianto E Wiria; Firdaus Hamid; Linda J Wammes; Erliyani Sartono; Adrian J F Luty; Eric A T Brienen; Maria Yazdanbakhsh; Lisette van Lieshout; Jaco J Verweij Journal: Malar J Date: 2013-05-24 Impact factor: 2.979
Authors: Christine M Cserti-Gazdewich; Aggrey Dhabangi; Charles Musoke; Isaac Ssewanyana; Henry Ddungu; Deborah Nakiboneka-Ssenabulya; Nicolette Nabukeera-Barungi; Arthur Mpimbaza; Walter H Dzik Journal: Br J Haematol Date: 2012-08-22 Impact factor: 6.998